Detalles de la búsqueda
1.
Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review.
Anticancer Drugs
; 29(5): 477-481, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29561309
2.
Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma.
BMC Cancer
; 14: 606, 2014 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25146150
3.
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.
JNCI Cancer Spectr
; 8(3)2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627238
4.
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma.
J Immunother Cancer
; 11(5)2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37236636
5.
Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the point.
Cancer Chemother Pharmacol
; 89(4): 565-569, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35147741
6.
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Cell Rep Med
; 3(10): 100783, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36260981
7.
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib.
Pharmaceuticals (Basel)
; 14(6)2021 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34073681
8.
Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience.
Cancers (Basel)
; 13(13)2021 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34201451
9.
Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients.
Cancers (Basel)
; 14(1)2021 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008333
10.
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 19(6): 501-509, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629300
11.
A simple and rapid liquid chromatography-mass spectrometry method to assay cabozantinib in plasma: Application to therapeutic drug monitoring in patients with renal cell carcinoma.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1138: 121968, 2020 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31931326
12.
Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study.
Clin Interv Aging
; 15: 1587-1598, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32982194
13.
"Real-world" evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy.
Urol Oncol
; 38(1): 2.e1-2.e9, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31447087
14.
Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database.
Eur J Cancer
; 125: 153-163, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31787484
15.
Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2.
Int J Cancer
; 125(4): 851-60, 2009 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19449377
16.
Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
Int J Cancer
; 125(10): 2307-15, 2009 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19610056
17.
Rechallenge of carboplatin-gemcitabine based chemotherapy for rapidly progressing metastatic collecting duct carcinoma of the kidney leading to a delayed and durable complete response: A case report.
Oncol Lett
; 17(3): 3576-3580, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30867800
18.
Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma.
Radiother Oncol
; 87(2): 195-200, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18342966
19.
Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer.
Eur J Cancer
; 97: 41-48, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29636272
20.
Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database.
Eur Urol Oncol
; 1(6): 467-475, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158090